Roles
Associate Professor of Neurology
Chief, Neuro-Oncology Division
Clinical Service Leader for Neuro-Oncology Service Line - Sylvester Comprehensive Cancer Center
Chair, Neuro-Oncology Site Disease Group
Neuro-Oncology Fellowship Program Director
Oncology Clinical Service Leader for Neuro-Oncology
-
Biography
Dr. De la Fuente is the Chief of the Neuro-Oncology Division and Director of the Neuro-Oncology Fellowship Program, Department of Neurology, University of Miami and Neuro-Oncology Clinical Service Leader for the Oncology Service Line at Sylvester Comprehensive Cancer Center. Dr. De la Fuente is a graduate of the Neuro-Oncology Fellowship program at Memorial Sloan Kettering Cancer Center in New York, where she served as Consultant in the Department of Neurology after finishing her fellowship. Dr. De la Fuente is an active member of the Society for Neuro-Oncology (SNO) where she serves as one of the co-chairs of the Women and Diversity Committee. Dr. De la Fuente has been appointed by the President of the Florida Senate as a Member of the Scientific Advisory Council of the Florida Center for Brain Tumor Research. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
No result found
-
Teaching Interests
Dr. De la Fuente is the director of the Neuro-oncology fellowship program. -
Research Interests
Dr. De la Fuente's research focuses on clinical and translational research in primary human brain tumors with a goal to develop innovative, more effective treatments as well as develop radiographic biomarkers to better assess the efficacy of those treatments. This effort has been conducted along two tracks 1) Optimizing therapy for patients with low- and high-grade glioma using a combined approach of targeted therapies and or immunotherapy, and 2) developing molecular imaging through collaborations with basic research scientists. Dr. De la Fuente has a strong interest in gliomas and metabolic pathway alterations, particularly isocitrate dehydrogenase (IDH) mutations. Her work has been specifically focused on IDH inhibitors for the treatment of IDH mutant gliomas as well as the identification and clinical application novel radiographic biomarkers for IDH mutant gliomas. Dr. De la Fuente is currently leading and collaborating in multiple active research projects with colleagues from Neurosurgery, Radiology, Medicine, Pediatrics, Medical Physics, and Radiation Oncology. Dr. De la Fuente is a Memorial Sloan Kettering trained neuro-oncologist serving as principal investigator for several clinical trials, including IISs, as well as collaborations within NIH-funded cooperative groups and industry.
Dr. De la Fuente is deeply interested and invested in achieving diversity, equity, and inclusion (DEI) in the academic medical environment. As part of this commitment, she currently serves as one of the co-chairs of the Women and Diversity Committee of the Society for Neuro-Oncology (SNO) and as the Equity Focused Clinical Investigator (EfCI) for University of Miami to North American Star Consortium (NASC). -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
-
Professional Activities
No result found